Global Antibacterial Hemostatic Gels Market Size Study, by Product Type (Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, Others), by Animal Type (Cats, Dogs, Horses, Others), by End Use (Homecare, Diagnostic Centres, Hospitals, Clinics, Others) and Regional Forecasts 2022-2032
Global Antibacterial Hemostatic Gels Market is valued at approximately USD 1.47 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.41% over the forecast period 2024-2032. Antibacterial hemostatic gels are cutting-edge wound care solutions engineered to arrest bleeding and prevent infections. These gels amalgamate hemostatic agents, which expedite blood clotting, with antibacterial properties to mitigate the risk of wound infections. Predominantly employed in surgical settings, trauma care, and first aid scenarios, these gels form a protective barrier over wounds while concurrently eliminating or inhibiting bacterial growth. This dual functionality promotes expedited healing and minimizes complications, rendering them invaluable in managing both minor and severe bleeding incidents.
The Global Antibacterial Hemostatic Gels Market growth is driven by including heightened healthcare expenditure, increased per capita income, a rising incidence of wound infections, technological advancements in wound care products, and the availability of a diverse array of antibacterial hemostatic gel products. Moreover, development of novel antibacterial hemostatic gels and increased focus on minimally invasive surgeries are anticipated to create lucrative opportunities for the market. However, high cost of advanced wound care products is going to impede the overall demand for the market during the forecast period 2024-2032.
The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is projected to dominate the antimicrobial hemostatic gels market in terms of revenue during the forecast period. This is primarily due to the high volume of surgeries performed in the region and the broad availability of hemostatic gel products. These factors collectively bolster market growth in North America. Furthermore, the market in Asia Pacific is anticipated to develop at the fastest rate over the forecast period 2024-2032.
Major market players included in this report are:Ethicon (Johnson & Johnson)
Baxter International Inc.
Pfizer Inc.
B. Braun Melsungen AG
C. R. Bard, Inc. (BD)
Medtronic plc
Integra LifeSciences Corporation
Sanofi
Z-Medica, LLC
HemCon Medical Technologies, Inc.
Marine Polymer Technologies, Inc.
Gelita Medical GmbH
The detailed segments and sub-segment of the market are explained below:By Product Type:
• Urinanalysis Testing Kits
• Hematology Testing Kits
• Blood Pressure Monitoring Devices
• Blood Glucose Monitoring Devices
• Others
By Animal Type:
• Cats
• Dogs
• Horses
• Others
By End Use:
• Homecare
• Diagnostic Centres
• Hospitals
• Clinics
• Others
By Region: North America:
• U.S.
• Canada
Europe:
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific:
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America:
• Brazil
• Mexico
• RoLA
Middle East & Africa:
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.